New in vitro findings about halogenated boroxine cytotoxicity and deregulation of cell death-related genes in GR-M melanoma cells

1. Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med 2004;351:998–1012. doi: 10.1056/NEJMra041245 Tsao H Atkins MB Sober AJ . Management of cutaneous melanoma . N Engl J Med 2004 ; 351 : 998 – 1012 . doi: 10.1056/NEJMra041245 Open DOISearch in Google Scholar

2. Hintzsche JD, Gorden NT, Amato CM, Kim J, Wuensch KE, Robinson SE, Applegate AJ, Couts KL, Medina TM, Wells KR, Wisell JA, McCarter MD, Box NF, Shellman YG, Gonzalez RC, Lewis KD, Tentler JJ, Tan AC, Robinson WA. Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma. Melanoma Res 2017;27:189–99. doi: 10.1097/CMR.0000000000000345 Hintzsche JD Gorden NT Amato CM Kim J Wuensch KE Robinson SE Applegate AJ Couts KL Medina TM Wells KR Wisell JA McCarter MD Box NF Shellman YG Gonzalez RC Lewis KD Tentler JJ Tan AC Robinson WA . Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma . Melanoma Res 2017 ; 27 : 189 – 99 . doi: 10.1097/CMR.0000000000000345 Open DOISearch in Google Scholar

3. Harel M, Ortenberg R, Varanasi SK, Mangalhara KC, Mardamshina M, Markovits E, Baruch EN, Tripple V, Arama-Chayoth M, Greenberg E, Shenoy A, Ayasun R, Knafo N, Xu S, Anafi L, Yanovich-Arad G, Barnabas GD, Ashkenazi S, Besser MJ, Schachter J, Bosenberg M, Shadel GS, Barshack I, Kaech SM, Markel G, Geiger T. Proteomics of melanoma response to immunotherapy reveals mitochondrial dependence. Cell 2019;179:236–50.e18. doi: 10.1016/j.cell.2019.08.012 Harel M Ortenberg R Varanasi SK Mangalhara KC Mardamshina M Markovits E Baruch EN Tripple V Arama-Chayoth M Greenberg E Shenoy A Ayasun R Knafo N Xu S Anafi L Yanovich-Arad G Barnabas GD Ashkenazi S Besser MJ Schachter J Bosenberg M Shadel GS Barshack I Kaech SM Markel G Geiger T . Proteomics of melanoma response to immunotherapy reveals mitochondrial dependence . Cell 2019 ; 179 : 236 – 50.e18 . doi: 10.1016/j.cell.2019.08.012 Open DOISearch in Google Scholar

4. Perini GF, Ribeiro GN, Pinto Neto JV, Campos LT, Hamerschlak N. BCL-2 as therapeutic target for hematological malignancies. J Hematol Oncol 2018;11(1):65. doi: 10.1186/s13045-018-0608-2 Perini GF Ribeiro GN Pinto Neto JV Campos LT Hamerschlak N . BCL-2 as therapeutic target for hematological malignancies . J Hematol Oncol 2018 ; 11 ( 1 ): 65 . doi: 10.1186/s13045-018-0608-2 Open DOISearch in Google Scholar

5. Murphy E, Imahashi K, Steenbergen C. Bcl-2 regulation of mitochondrial energetics. Trends Cardiovas Med 2005;15:283–90. doi: 10.1016/j.tcm.2005.09.002 Murphy E Imahashi K Steenbergen C . Bcl-2 regulation of mitochondrial energetics . Trends Cardiovas Med 2005 ; 15 : 283 – 90 . doi: 10.1016/j.tcm.2005.09.002 Open DOISearch in Google Scholar

6. Nys K, Agostinis P. Bcl-2 family members: essential players in skin cancer. Cancer Lett 2012;320:1–13. doi: 10.1016/j.canlet.2012.01.031 Nys K Agostinis P . Bcl-2 family members: essential players in skin cancer . Cancer Lett 2012 ; 320 : 1 – 13 . doi: 10.1016/j.canlet.2012.01.031 Open DOISearch in Google Scholar

7. Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 2011;18:571–80. doi: 10.1038/cdd.2010.191 Kang R Zeh HJ Lotze MT Tang D . The Beclin 1 network regulates autophagy and apoptosis . Cell Death Differ 2011 ; 18 : 571 – 80 . doi: 10.1038/cdd.2010.191 Open DOISearch in Google Scholar

8. Mgrditchian T, Arakelian T, Paggetti J, Noman MZ, Viry E, Moussay E, Van Moer K, Kreis S, Guerin C, Buart S, Robert C, Borg C, Vielh P, Chouaib S, Berchem G, Janji B. Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner. Proc Natl Acad Sci U S A 2017;114(44):E9271–9. doi: 10.1073/pnas.1703921114 Mgrditchian T Arakelian T Paggetti J Noman MZ Viry E Moussay E Van Moer K Kreis S Guerin C Buart S Robert C Borg C Vielh P Chouaib S Berchem G Janji B . Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner . Proc Natl Acad Sci U S A 2017 ; 114 ( 44 ): E9271 – 9 . doi: 10.1073/pnas.1703921114 Open DOISearch in Google Scholar

9. Pojskić L, Haverić S, Lojo-Kadrić N, Hadzić M, Haverić A, Galić Z, Galić B, Vullo D, Supuran CT, Milos M. Effects of dipotassium-trio xohydroxytetrafluorotriborate, K₂[B₃O₃F₄OH], on cell viability and gene expression of common human cancer drug targets in a melanoma cell line. J Enzyme Inhib Med Chem 2016;31:999–1004. doi: 10.3109/14756366.2015.1078329 Pojskić L Haverić S Lojo-Kadrić N Hadzić M Haverić A Galić Z Galić B Vullo D Supuran CT Milos M . Effects of dipotassium-trio xohydroxytetrafluorotriborate, K₂[B₃O₃F₄OH], on cell viability and gene expression of common human cancer drug targets in a melanoma cell line . J Enzyme Inhib Med Chem 2016 ; 31 : 999 – 1004 . doi: 10.3109/14756366.2015.1078329 Open DOISearch in Google Scholar

10. Galić B. Boroxine composition for removal of skin changes. Patent US 8, 278, 289 B22 October 2, 2012 [displayed 28 February 2023]. Available at https://patentimages.storage.googleapis.com/9b/b7/82/939ed401b099e9/US8278289.pdf Galić B . Boroxine composition for removal of skin changes . Patent US 8, 278, 289 B22 October 2, 2012 [displayed 28 February 2023]. Available at https://patentimages.storage.googleapis.com/9b/b7/82/939ed401b099e9/US8278289.pdf Search in Google Scholar

11. Ivanković S, Stojković R, Galić Z, Galić B, Ostojić J, Marasović M, Miloš M. In vitro and in vivo antitumor activity of the halogenated boroxine dipotassium trioxohydroxytetrafluorotriborate (K₂[B₃O₃F₄OH]). J Enzyme Inhib Med Chem 2015;30:354–9. doi: 10.3109/14756366.2014.926344 Ivanković S Stojković R Galić Z Galić B Ostojić J Marasović M Miloš M . In vitro and in vivo antitumor activity of the halogenated boroxine dipotassium trioxohydroxytetrafluorotriborate (K₂[B₃O₃F₄OH]) . J Enzyme Inhib Med Chem 2015 ; 30 : 354 – 9 . doi: 10.3109/14756366.2014.926344 Open DOISearch in Google Scholar

12. Hadžić M, Pojskić L, Lojo-Kadrić N, Haverić A, Ramić J, Galić B, Haverić S. Novel boron-containing compound, halogenated boroxine, induces selective cytotoxicity through apoptosis triggering in UT-7 leukemia. J Biochem Mol Toxicol 2022;36(5):e23005. doi: 10.1002/jbt.23005 Hadžić M Pojskić L Lojo-Kadrić N Haverić A Ramić J Galić B Haverić S . Novel boron-containing compound, halogenated boroxine, induces selective cytotoxicity through apoptosis triggering in UT-7 leukemia . J Biochem Mol Toxicol 2022 ; 36 ( 5 ): e23005 . doi: 10.1002/jbt.23005 Open DOISearch in Google Scholar

13. Haverić S, Haverić A, Bajrović K, Galić B, Maksimović M. Effects of dipotassium trioxohydroxytetrafluorotriborate (K₂[B₃O₃F₄OH]) on genetic material and inhibition of cell division in human cell cultures. Drug Chem Toxicol 2011;34:250–4. doi: 10.3109/01480545.2010.507207 Haverić S Haverić A Bajrović K Galić B Maksimović M . Effects of dipotassium trioxohydroxytetrafluorotriborate (K₂[B₃O₃F₄OH]) on genetic material and inhibition of cell division in human cell cultures . Drug Chem Toxicol 2011 ; 34 : 250 – 4 . doi: 10.3109/01480545.2010.507207 Open DOISearch in Google Scholar

14. Islamović S, Galić B, Miloš M. A study of the inhibition of catalase by dipotassium trioxohydroxytetrafluorotriborate K₂[B₃O₃F₄OH]. J Enzyme Inhib Med Chem 2014;29:744–8. doi: 10.3109/14756366.2013.848203 Islamović S Galić B Miloš M . A study of the inhibition of catalase by dipotassium trioxohydroxytetrafluorotriborate K₂[B₃O₃F₄OH] . J Enzyme Inhib Med Chem 2014 ; 29 : 744 – 8 . doi: 10.3109/14756366.2013.848203 Open DOISearch in Google Scholar

15. Ostojić J, Herenda S, Galijašević S, Galić B, Miloš M. Inhibition of horseradish peroxidase activity by boroxine derivative, dipotassium-tr ioxohydroxytetrafluorotriborate K₂[B₃O₃F₄OH]. J Chem 2017;2017:8134350. doi: 10.1155/2017/8134350 Ostojić J Herenda S Galijašević S Galić B Miloš M . Inhibition of horseradish peroxidase activity by boroxine derivative, dipotassium-tr ioxohydroxytetrafluorotriborate K₂[B₃O₃F₄OH] . J Chem 2017 ; 2017 : 8134350 . doi: 10.1155/2017/8134350 Open DOISearch in Google Scholar

16. Herenda S, Ostojić J, Hasković E, Hasković D, Miloš M, Galić B. Electrochemical investigation of the influence of K₂[B₃O₃F₄OH] on the activity of immobilized superoxide dismutase. Int J Electrochem Sci 2018;13:3279–87. doi: 10.20964/2018.04.35 Herenda S Ostojić J Hasković E Hasković D Miloš M Galić B . Electrochemical investigation of the influence of K₂[B₃O₃F₄OH] on the activity of immobilized superoxide dismutase . Int J Electrochem Sci 2018 ; 13 : 3279 – 87 . doi: 10.20964/2018.04.35 Open DOISearch in Google Scholar

17. Vullo D, Miloš M, Galić B, Scozzafava A, Supuran CT. Dipotassium trioxohydroxytetrafluorotriborate K₂[B₃O₃F₄OH], is a potent inhibitor of human carbonic anhydrases. J Enzyme Inhib Med Chem 2015;30:341–4. doi: 10.3109/14756366.2014.918610 Vullo D Miloš M Galić B Scozzafava A Supuran CT . Dipotassium trioxohydroxytetrafluorotriborate K₂[B₃O₃F₄OH], is a potent inhibitor of human carbonic anhydrases . J Enzyme Inhib Med Chem 2015 ; 30 : 341 – 4 . doi: 10.3109/14756366.2014.918610 Open DOISearch in Google Scholar

18. Ivanković S, Stojković R, Maksimović M, Galić B, Miloš M. Impact of calcium ion on cytotoxic effect of the boroxine derivative, K₂[B₃O₃F₄OH]. J Enzyme Inhib Med Chem 2016;31(Suppl 3):70–4. doi: 10.1080/14756366.2016.1204611 Ivanković S Stojković R Maksimović M Galić B Miloš M . Impact of calcium ion on cytotoxic effect of the boroxine derivative, K₂[B₃O₃F₄OH] . J Enzyme Inhib Med Chem 2016 ; 31 ( Suppl 3 ): 70 – 4 . doi: 10.1080/14756366.2016.1204611 Open DOISearch in Google Scholar

19. Hadzic M, Sun Y, Tomic N, Tsirvouli E, Kuiper M, Pojskic L. Halogenated boroxine increases propensity to apoptosis in leukemia (UT-7) but not non-tumor cells in vitro. FEBS Open Bio 2023;13:143–53. doi: 10.1002/2211-5463.13522 Hadzic M Sun Y Tomic N Tsirvouli E Kuiper M Pojskic L . Halogenated boroxine increases propensity to apoptosis in leukemia (UT-7) but not non-tumor cells in vitro . FEBS Open Bio 2023 ; 13 : 143 – 53 . doi: 10.1002/2211-5463.13522 Open DOISearch in Google Scholar

20. Easty DJ, Guthrie BA, Maung K, Farr CJ, Lindberg RA, Toso RJ, Herlyn M, Bennett DC. Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression. Cancer Res 1995;55:2528–32. PMID: 7780963 Easty DJ Guthrie BA Maung K Farr CJ Lindberg RA Toso RJ Herlyn M Bennett DC . Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression . Cancer Res 1995 ; 55 : 2528 – 32 . PMID: 7780963 Search in Google Scholar

21. Panda SK, Ravindran B. Isolation of human PBMCs. Bio-protocol 2013;3(3):e323. doi: 10.21769/BioProtoc.323 Panda SK Ravindran B . Isolation of human PBMCs . Bio-protocol 2013 ; 3 ( 3 ): e323 . doi: 10.21769/BioProtoc.323 Open DOISearch in Google Scholar

22. Rampersad SN. Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays. Sensors 2012;12:12347–60. doi: 10.3390/s120912347 Rampersad SN . Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays . Sensors 2012 ; 12 : 12347 – 60 . doi: 10.3390/s120912347 Open DOISearch in Google Scholar

23. Kumar P, Nagarajan A, Uchil PD. Analysis of cell viability by the alamarBlue assay. Cold Spring Harb Protoc 2018;6:095489. doi: 10.1101/pdb.prot095489 Kumar P Nagarajan A Uchil PD . Analysis of cell viability by the alamarBlue assay . Cold Spring Harb Protoc 2018 ; 6 : 095489 . doi: 10.1101/pdb.prot095489 Open DOISearch in Google Scholar

24. AlamarBlue^® Assay, U.S. Patent No. 5,501,959 [displayed 22 February 2023]. Available at https://tools.thermofisher.com/content/sfs/manuals/PI-DAL1025-1100_TI%20alamarBlue%20Rev%201.1.pdf AlamarBlue^® Assay, U.S. Patent No. 5,501,959 [displayed 22 February 2023] . Available at https://tools.thermofisher.com/content/sfs/manuals/PI-DAL1025-1100_TI%20alamarBlue%20Rev%201.1.pdf Search in Google Scholar

25. Wagner EM. Monitoring gene expression: quantitative real-time rt-PCR. Methods Mol Biol 2013;1027:19–45. doi: 10.1007/978-1-60327-369-5_2 Wagner EM . Monitoring gene expression: quantitative real-time rt-PCR . Methods Mol Biol 2013 ; 1027 : 19 – 45 . doi: 10.1007/978-1-60327-369-5_2 Open DOISearch in Google Scholar

26. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30(9):e36. doi: 10.1093/nar/30.9.e36 Pfaffl MW Horgan GW Dempfle L . Relative expression software tool (REST) for group wise comparison and statistical analysis of relative expression results in real-time PCR . Nucleic Acids Res 2002 ; 30 ( 9 ): e36 . doi: 10.1093/nar/30.9.e36 Open DOISearch in Google Scholar

27. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2^-ΔΔCT method. Methods 2001;25:402–8. doi: 10.1006/meth.2001.1262 Livak KJ Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2^-ΔΔCT method . Methods 2001 ; 25 : 402 – 8 . doi: 10.1006/meth.2001.1262 Open DOISearch in Google Scholar

28. Zhang XD, Qi L, Wu JC, Qin ZH. DRAM1 regulates autophagy flux through lysosomes. PLoS One 2013;8(5):e63245. doi: 10.1371/journal.pone.0063245 Zhang XD Qi L Wu JC Qin ZH . DRAM1 regulates autophagy flux through lysosomes . PLoS One 2013 ; 8 ( 5 ): e63245 . doi: 10.1371/journal.pone.0063245 Open DOISearch in Google Scholar

29. Galavotti S, Bartesaghi S, Faccenda D, Shaked-Rabi M, Sanzone S, McEvoy A, Dinsdale D, Condorelli F, Brandner S, Campanella M, Grose R, Jones C, Salomoni P. The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. Oncogene 2013;32:699–712. doi: 10.1038/onc.2012.111 Galavotti S Bartesaghi S Faccenda D Shaked-Rabi M Sanzone S McEvoy A Dinsdale D Condorelli F Brandner S Campanella M Grose R Jones C Salomoni P . The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells . Oncogene 2013 ; 32 : 699 – 712 . doi: 10.1038/onc.2012.111 Open DOISearch in Google Scholar

30. Vats S, Manjithaya R. A reversible autophagy inhibitor blocks autophagosome-lysosome fusion by preventing Stx17 loading onto autophagosomes. Mol Biol Cell 2019;30:2283–95. doi: 10.1091/mbc.E18-08-0482 Vats S Manjithaya R . A reversible autophagy inhibitor blocks autophagosome-lysosome fusion by preventing Stx17 loading onto autophagosomes . Mol Biol Cell 2019 ; 30 : 2283 – 95 . doi: 10.1091/mbc.E18-08-0482 Open DOISearch in Google Scholar

31. Kumar AV, Mills J, Lapierre LR. Selective autophagy receptor p62/SQSTM1, a pivotal player in stress and aging. Front Cell Dev Biol 2022;10:793328. doi: 10.3389/fcell.2022.793328 Kumar AV Mills J Lapierre LR . Selective autophagy receptor p62/SQSTM1, a pivotal player in stress and aging . Front Cell Dev Biol 2022 ; 10 : 793328 . doi: 10.3389/fcell.2022.793328 Open DOISearch in Google Scholar